Andreas Wicki, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 1,153,534 shares at $58.81 ($68.2M) on 2022-11-04, disclosed to the SEC on 2022-11-04.
Open-market sale of $68.2M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.81 | 164,676 | $9.7M | 14.2% |
| 2 | $58.81 | 164,676 | $9.7M | 14.2% |
| 3 | $59.44 | 254,141 | $15.1M | 22.2% |
| 4 | $59.44 | 254,141 | $15.1M | 22.2% |
| 5 | $58.81 | 157,950 | $9.3M | 13.6% |
| 6 | $58.81 | 157,950 |
| $9.3M |
| 13.6% |
| Total | $59.09 avg | 1,153,534 | $68.2M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-16 | $6.1M | — | Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-08-10 | $62.2M | — | Filing → |